company

news

and

events


July 27, 2001

nanotype GmbH announces funding of a nanobiotechnology project grant by the German Ministry of Research and Technology BMBF. The grant will support a research collaboration between the chair for applied physics (Prof. Hermann Gaub, www.biophysik.physik.uni-muenchen.de/) of Munich University and the company.


July 17, 2001

nanotype GmbH announces the closing of its start-up financing round in the amount of 3.25M Euros. Capital Stage AG (Hamburg, Germany) is the lead investor in this round. Other investors are Saechsische Landesbank Corporate Finance Holding (Leipzig, Germany) and Technologiebeteiligungsgesellschaft der Deutschen Ausgleichsbank.


July 1st, 2001

nanotype relocated to new laboratory space in Gräfelfing in the Martinsried area close to Munich, Germany, in summer 2001. The Martinsried area hosts the largest biotech cluster on the European continent.
> The new address
> Pictures from the new lab


February 4, 2001

nanotype GmbH announces that Dr. Werner Wolf has become a shareholder. He will become a director after the incorporation of nanotype into a joint stock company. Dr. Wolf was a board member of Boehringer Mannheim and a top manager of the Biochemica Division of that company. He also served as chairman of the European Yeast Industrial Platform and the European Structural Biology Industrial Platform. He is chairman or member of several boards of biotech companies and is a senior science & technology advisor to the venture capital firm TVM.


August 2, 2000

nanotype GmbH announces the closing of its seed-financing round. BioM Munich Biotech Development AG (Martinsried, Germany) is the investor.


July 28, 2000

nanotype, a spin off from CeNS is officially founded as a GmbH.


July 26, 2000

Munich Businessplan Competition (Münchner Businessplan-Wettbewerb) has selected nanotype as the third winner on the 2000 competition. The award amounts to DEM 30000 for the successful nanotype team of Christian Albrecht, Martin Benoit, Gunnar Brink, Filipp Oesterhelt, Hermann Gaub, and Boris Steipe.


Last Update: 09/13/01